Related Experiment Video
Updated: Sep 13, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
The Effect of Intravenous Albumin Administration Before Exchange Transfusion in Infants With Hyperbilirubinemia: A
Romina Kamyab1, Siroos Hemmatpour2, Ramyar Rahimi Darehbagh3,4,5,6
1School of Medicine, Besat Hospital Kurdistan University of Medical Sciences Sanandaj Iran.
Background And Aims:
This meta-analysis aimed to assess the impact of intravenous albumin administration before exchange transfusion in infants diagnosed with hyperbilirubinemia.
Methods:
A comprehensive search was conducted in multiple electronic databases, including PubMed (Medline), Scopus, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov, using relevant keywords. The quality of the included randomized controlled trials (RCTs) was evaluated using the Cochrane Risk of Bias tool. Statistical analyses were performed using STATA (Version 18) and RevMan (Version 5).
Results:
Four RCTs met the inclusion criteria. Pooled analysis indicated a nonsignificant reduction in total bilirubin levels following intravenous albumin administration (SMD: -2.19; 95% CI: -4.79 to 0.41; I² = 68.03%; p for heterogeneity = 0.001). Subgroup analysis revealed no significant reduction in early bilirubin measurements (≤ 6 h), but a statistically significant reduction was observed in later measurements (12-24 h) (SMD: -2.91; 95% CI: -4.93 to -0.89). The duration of phototherapy was significantly reduced in the albumin group compared to placebo (WMD: -11.23; 95% CI: -21.28 to -1.19; I² = 76.12%; p for heterogeneity = 0.03).
Conclusion:
While intravenous albumin administration before exchange transfusion did not show a statistically significant effect on total bilirubin levels overall, a potential bilirubin-lowering effect was observed when measured at later time points. Moreover, albumin significantly reduced the duration of phototherapy. These findings suggest potential clinical benefit, though further high-quality RCTs are warranted.
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

